Global Vutrisiran Market to Surpass US$ 2 Billion in 2023, expanding at a 12% CAGR from 2023 to 2033 | FMI Report

During the forecast period 2023 to 2033, the Vutrisiran market is expected to grow at a value of 12% CAGR, according to Future Market Insights. By the year 2033, the global market for Vutrisiran is expected to rise up to a market valuation of US$ 2087 Million. The growth of the market can be attributed to Vutrisiran offering hope and a new treatment option for patients with hereditary transthyretin-mediated amyloidosis (hATTR).

the launch of Vutrisiran, patients with hATTR has a new, promising treatment option that addresses the underlying cause of the disease. Vutrisiran is a small interfering RNA (siRNA) molecule that works by inhibiting the production of abnormal TTR protein, which is responsible for the buildup of amyloid deposits. By reducing the production of abnormal TTR, Vutrisiran slows down the progression of the disease and improves the quality of life for patients.

Download a sample to obtain additional highlights and key points on various market segments and their impact in the coming years @
https://www.futuremarketinsights.com/reports/sample/rep-gb-16993

The launch of Vutrisiran is a significant milestone in the field of hATTR treatment. The medication has shown promising results in clinical trials, demonstrating its safety and efficacy in reducing TTR protein levels and improving clinical outcomes in patients. In a Phase III clinical trial, Vutrisiran was found to reduce TTR protein levels by 85% on average, and nearly all patients experienced a significant improvement in their neurological symptoms.

The launch of Vutrisiran is a game-changer for the hATTR market, as it offers a new and effective treatment option for patients with this devastating disease. The medication can potentially improve the lives of thousands of individuals living with hATTR and their families by slowing down the progression of the disease and improving clinical outcomes.

Key Takeaways from the Market Study

• The global Vutrisiran market is expected to grow with a 12% CAGR during 2023 to 2033.
• Hospital pharmacies are expected to hold 46% of the market share in 2023 for Vutrisiran market.
• North America is expected to possess 45% market share for Vutrisiran market in 2023.
• Europe vutrisiran market size is expected to possess 41% market share in 2023.

“The safety and efficacy of Vutrisiran have been demonstrated in clinical trials. Owing to this, key players are investing in the development of vutrisiran,”statesan FMI analyst

Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16993

Competitive Landscape

Key players in the vutrisiran market are Alnylam Pharmaceuticals, Inc., Orphalan, AstraZeneca, Vivet Therapeutics, Pfizer, Ultragenyx Pharmaceutical, Valeant Pharmaceuticals International, Inc., Noblepharma Co., Ltd., Merck & Co., Inc., Teva Pharmaceuticals

• Alnylam Pharmaceuticals has a strong pipeline of other RNAi-based therapies in development for a range of diseases. The success of Vutrisiran has helped to drive investor confidence in the company and increase funding for its other pipeline drugs, which could result in new treatment options for patients.
• Alnylam Pharmaceuticals has established patient access programs to ensure that patients who need Vutrisiran have access to the drug. These programs provide financial assistance, support services, and other resources to help patients access and afford Vutrisiran.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Vutrisiran market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Drug Class (Antisense Oligonucleotides, Nucleic Acids, Nucleotide, Nucleosides) Route of Administration (Injectable, Parenteral, Subcutaneous) Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)

Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/16993

Key Segments Profiled in the Vutrisiran Industry Survey

Drug Class:

• Antisense Oligonucleotides
• Nucleic Acids
• Nucleotide
• Nucleosides

Route of Administration:

• Injectable
• Parenteral
• Subcutaneous

Distribution Channel:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

More Trending Reports by Future Market Research:

Empty Capsules Market : The global sales of empty capsules are anticipated to reach US$ 2.3 Billion in 2023. The market is further expected to increase at 7.9% CAGR during the forecast period, totaling a valuation of US$ 4.9 Billion by 2033.

Dermal Fillers Market : Dermal Fillers Market is projected to exhibit 7.5% CAGR between 2023 and 2033. They are used to rejuvenate different facial areas associated with various functionalities. The rising demand for facelift or face line corrections in various emerging countries is enabling the market growth.

Connected Drug Delivery Devices Market: The global Connected Drug Delivery Devices Market size was estimated at US$ 330 Mn in 2021, and is expected to reach US$ 1.6 Bn by 2028, expanding at a stellar CAGR of 23.6%.

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs